| Diagnostics – Increasing of total value creation in healthcare |
There is a strong trend toward the implementation of earlier, more selective or even individualised treatment that enlists the help of innovative diagnostic procedures to improve medical practice. More precise diagnosis and tailored treatment can help improve clinical outcomes, avoid side effects, and contribute to overall cost savings. Innovative diagnostics are expected to generate an ever increasing share of the total value creation in healthcare and open up new markets and investment possibilities.
Wellington believes that highly attractive opportunities exist for companies, especially in the fields of
- early diagnosis of life-threatening diseases such as cancer
- monitoring of chronic diseases
- point-of-care diagnosis
- companion diagnostics
- personalized medicine.
A key factor in innovation in these areas is a detailed understanding of the underlying pathophysiology and molecular pathways, including inter-individual / genetic differences and the use of molecular biology with highly sensitive and specific measurement technologies for the quantification of key disease markers and parameters.
